Exalenz Bioscience
Exalenz Bioscience is a medical technology provider based in Israel, specializing in the development of innovative breath tests for disease diagnosis. Their non-invasive solutions enable clinicians to detect a broad range of respiratory and digestive conditions. They are committed to setting the gold standard in breath diagnostics and strive to improve patient care through accurate, reliable, and easy-to-use tests.
Exalenz mesh technology utilizes tiny sensors in nanoscale (smallest possible size) to measure hydrogen and carbon dioxide concentrations in breath samples. Their products, which include user-friendly diagnostics kits, breath sample collection technology, and handheld diagnostic devices, make it simple to analyze patients for diseases and help clinicians predict treatments. They also offer software tools to support customers in the use, analysis, and validation of their products.
Exalenz Bioscience offer solutions for the diagnosis of respiratory infectious diseases such as COVID-19, as well as for diagnosing gastrointestinal conditions such as H. Pylori. Their products are used by hospitals, clinics, and laboratories worldwide to improve patient outcomes.
Exalenz Bioscience stand out in the healthcare sector for their patented mesh technology and innovative tools for the diagnosis of digestive and respiratory diseases. Their products are designed to be reliable, effective, accurate, and easy to use, helping clinicians make informed decisions regarding patient care.